Buy me a coffee
Home › FDA recalls › Ascend Laboratories
CLASS II · ModerateFDA

Ascend Laboratories, LLC recalls Ascend Laboratories

📅 Apr 27, 2026 · 📍 Nationwide
Recalling company
Ascend Laboratories, LLC
Product
Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.
Reason
Failed Dissolution Specifications
Classification
Class II – may cause temporary or medically reversible health consequences
Recall date
Apr 27, 2026
Reported
May 20, 2026
Distribution
U.S. Nationwide
Status
Ongoing
Quantity
17,304 100-count bottles
Lot / codes
Lot # 25140859; Exp. Date: Jan 2027
Company location
Bedminster, NJ
Recall type
Voluntary: Firm initiated
Recall number
D-0547-2026
Agency
U.S. Food and Drug Administration (FDA)

View official FDA notice ↗ Search recall number D-0547-2026 in the FDA Enforcement Report. Also see FDA recall press releases.

If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.